Veklury
News/ News/ Sales and Marketing
FDA clears Gilead’s Veklury for COVID outpatients
Phil Taylor
antiviral, coronavirus, COVID-19, fda, Gilead Sciences, NIH, Veklury
0 Comment
Gilead says Veklury should work against COVID-19 variants
Phil Taylor
coronavirus, COVID-19, drug resistance, Gilead Sciences, remdesivir, Veklury
0 Comment
News/ News/ Sales and Marketing
Gilead Q3 revenue rise bolstered by $873m Veklury sales
Phil Taylor
coronavirus, COVID-19, Financial, Gilead Sciences, remdesivir, Veklury
0 Comment
BioSig abandons COVID-19 drug trial on safety concerns
Phil Taylor
antiviral, BioSig Technologies, coronavirus, COVID-19, Gilead Sciences, Veklury
0 Comment
Gilead’s remdesivir finally gets US approval
George Underwood
coronavirus, COVID-19, Gilead, remdesivir, Veklury
0 Comment